AzTrials
AzTrials

Medically Unexplained SymptomsNCT07007013

Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study

A study testing Humor therapy in people with Medically Unexplained Symptoms, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy) Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Medically Unexplained Symptoms
What is being tested?
Humor therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteSpain
Study dates
1 Sep 2025to 2 Oct 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants may be included in the trial if they meet all of the following inclusion criteria:
  • Men and women over 18 years of age.
  • Diagnosed with the condition under study (see Section 2: Definitions).
  • Expected to undergo follow-up for their condition at the study center.
  • Ability to participate in the required assessments.
  • Legal capacity to provide informed consent.
  • Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Who cannot join

  • Participants will be excluded if they meet any of the following exclusion criteria:
  • Participants diagnosed with any of the following conditions:
  • Severe mental health disorder, as determined by the investigator
  • Cognitive impairment of any etiology, as recorded in the medical history
  • Treatment for the condition under study using community-based resources prescribed in Primary Care within the past 6 months.
  • Cognitive or affective disorders that limit the ability to comply with study procedures.
  • Participation in another study involving an experimental intervention during the period of the present trial and/or requiring visit schedules that are incompatible with this trial.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • CAPI Baix A Mar (CSAPG)

    Vilanova i la Geltrú, Barcelona, 08800

Other trials in Spain

About this study

This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)

Being tested
Humor therapy
Keywords
Medically unexplained symptoms
Medical subject headings
Medically Unexplained Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Humor therapyOther

    The intervention consists of a cycle of 8 group sessions (one per week) led by trained professionals specialized in humor ('clown doctors'). Each session will last approximately 90 to 120 minutes

Study groups in NCT07007013
Study groupRoleWhat they receive
humor therapyExperimentalAll participants will receive an intervention based on humor therapy
Receives: Other: Humor therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. emotional well-being

    Emotional well-being will be measured before-after intervention through the Warwick-Edinburgh Mental Well-being Scale (WEMWBS). Range scale: 14-70. Higher scores indicate greater well-being.

    Measured: From baseline to 6 months after ending the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jun 2025
  2. Study start1 Sep 2025
  3. Primary completion2 Oct 2026
  4. Study completion2 Oct 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
28 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07007013
Sponsor's protocol ID
CSAPG-75
Status last verified
Oct 2026
First submitted
28 May 2025
Last updated
27 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Questions about this trial

What is this clinical trial studying?

A study testing Humor therapy in people with Medically Unexplained Symptoms, run by Consorci Sanitari de l'Alt Penedès i Garraf at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

emotional well-being (time frame: From baseline to 6 months after ending the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT07007013 | AzTrials